(Adds China context)
Oct 12 (Reuters) - Australian infant formula maker Bellamy's Australia Ltd BAL.AX said on Thursday it expects its core business to post revenue growth of about 15 percent to 20 percent in fiscal 2018, an increase over previous guidance.
"Early results in FY18 have been positive and consequently Bellamy's is upgrading its FY18 guidance for its core business," the company said in a statement.
Bellamy's said its earlier guidance was for revenue growth of between 5 percent and 10 percent.
The guidance, however, excludes the company's newly acquired Camperdown operations, which until recently were suspended from shipping infant formula to China by Chinese regulators. said its China Food and Drug Administration registration would still pose a challenge to its proposed turnaround. ($1 = 1.2840 Australian dollars)